eligibility for clinicaltrials:NCT01813292 [clinicaltrials_resource:4d6ecbeada74d1459943832908dd1a38]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT01813292 [clinicaltrials_resource:4d6ecbeada74d1459943832908dd1a38]
Bio2RDF identifier
4d6ecbeada74d1459943832908dd1a38
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4d6ecbeada74d1459943832908dd1a38
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
maximum age [clinicaltrials_vocabulary:maximum-age]
minimum age [clinicaltrials_vocabulary:minimum-age]
study population [clinicaltrials_vocabulary:study-population]
HIV+ male patients treated by TRUVADA® or VIREAD® for more than 60 months.
text [clinicaltrials_vocabulary:text]
Inclusion Criteria:
...... g chemotherapy or radiotherapy
identifier
clinicaltrials_resource:4d6ecbeada74d1459943832908dd1a38
title
eligibility for clinicaltrials:NCT01813292
@en
type
label
eligibility for clinicaltrials ...... ecbeada74d1459943832908dd1a38]
@en